Skip to main content
Log in

Pharmacokinetics of Indomethacin in Pregnancy

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Background and objectives

Although indomethacin has been widely used for the treatment of preterm labor over the past 40 years, there are few reports regarding its pharmacokinetics in pregnant women.

Methods

This opportunistic study assessed the steady-state pharmacokinetics of indomethacin in pregnant subjects to whom an oral dose of 25 mg every 6 h was prescribed. Indomethacin concentrations in plasma and urine were analyzed by a validated high-performance liquid chromatography method with mass spectrometric detection.

Results

The mean area under the plasma concentration versus time curve at steady state (AUCss) was 1.91 ± 0.53 μg·h/mL, mean peak plasma concentration (C max) was 1.02 ± 0.49 μg/mL, and mean time to reach C max (t max) was 1.3 ± 0.7 h. The mean apparent clearance at steady state was 14.5 ± 5.5 L/h, which is higher than the apparent clearance reported in the literature for non-pregnant subjects. Indomethacin crosses the placenta; the mean fetal/maternal ratio from five sets of cord blood samples collected at delivery was 4.0 ± 1.1.

Conclusions

Further studies are needed to determine whether any dose adjustments are necessary as a result of the increased clearance of indomethacin during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gamissans O, Balasch J. Prostaglandin synthetase inhibitors in the treatment of preterm birth. In: Fuchs A-R, Stubblefield PG, Fuchs F, editors. Preterm birth: causes, prevention, and management. 2nd ed. New York: McGraw-Hill; 1993. p. 309–32.

    Google Scholar 

  2. Zuckerman H, Shalev E, Gilad G, et al. Further study of the inhibition of premature labor by indomethacin. Part II: double-blind study. J Perinatal Med. 1984;12:25–9.

    Article  CAS  Google Scholar 

  3. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obst Gynecol. 1974;44:787–92.

    CAS  Google Scholar 

  4. Wiqvist N. Endogenous prostaglandins in normal pregnancy and labor. Pharmacol Ther B. 1975;1:297–310.

    CAS  PubMed  Google Scholar 

  5. Rane A, Oelz O, Frolich JC, et al. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther. 1978;23:658–68.

    CAS  PubMed  Google Scholar 

  6. Helleberg L. Clinical Pharmacokinetics of indomethacin. Clin Pharmacokinet. 1981;6:245–58.

    Article  CAS  PubMed  Google Scholar 

  7. Alván G, Orme M, Bertilsson L, et al. Pharmacokinetics of indomethacin. Clin Pharmacol Ther. 1975;18:364–73.

    PubMed  Google Scholar 

  8. Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin N Am. 2012;39:77–87.

    Article  Google Scholar 

  9. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33:328–43.

    Article  CAS  PubMed  Google Scholar 

  10. Wang X, Vernikovskaya DI, Nanovskaya TN, et al. A liquid chromatography method with single quadrupole mass spectrometry for quantitative determination of indomethacin in maternal plasma and urine of pregnant patients. J Pharm Biomed Anal. 2013;78–79:123–8.

    Article  PubMed  Google Scholar 

  11. Soback S, Britzi M. Absorption-dependent apparent volume of distribution at steady state (Vss/F) in pharmacokinetic data analysis. J Vet Pharmacol Ther. 2011;34:512–4.

    Article  CAS  PubMed  Google Scholar 

  12. Hakkola J, Raunio H, Purkunen R, et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol. 1996;52:379–83.

    Article  CAS  PubMed  Google Scholar 

  13. Niebyl JR, Blake DA, White RD, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 1980;136:1014–9.

    CAS  PubMed  Google Scholar 

  14. Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol. 2002;45:99–113.

    Article  PubMed  Google Scholar 

  15. Baber N, Halliday LD, van den Heuvel WJ, et al. Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders. Ann Rheum Dis. 1979;38:128–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Traeger A, Noschel H, Zaumseil J. Pharmacokinetics of indomethacin in pregnant and parturient women and in their newborn infants. Zentralbl Gynakol. 1973;95:635–41.

    CAS  PubMed  Google Scholar 

  17. Burton ME, Shaw LM, Schentag JJ, et al., editors. Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.

    Google Scholar 

  18. Vree TB, Biggelaar-Martea M, Verwey-van Wissen CP. Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis: preliminary pharmacokinetics and effect of probenecid. J Chromatogr. 1993;616:271–82.

    Article  CAS  PubMed  Google Scholar 

  19. Nakajima M, Inoue T, Shimada N, et al. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Disp. 1998;26:261–6.

    CAS  Google Scholar 

  20. Hebert MF. Impact of pregnancy on maternal pharmacokinetics of medications. In: Mattison DR, editor. Clinical pharmacology during pregnancy. San Diego: Elsevier; 2013. p. 17–40.

    Chapter  Google Scholar 

  21. Choi SY, Koh KH, Jeong H. Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013;41:263–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Moise KJ Jr, Ou CN, Kirshon B, et al. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol. 1990;162:549–54.

    Article  CAS  PubMed  Google Scholar 

  23. Kirshon B, Moise KJ Jr, Mari G, et al. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol. 1991;8:86–8.

    Article  CAS  PubMed  Google Scholar 

  24. Rainsford KD, James C, Hunt RH, et al. Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers. Clin Pharmacol Ther. 1992;51:415–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grant U10HD047891 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Obstetrical Pharmacology Research Units Network (OPRU), to G.D.V. Hankins. The authors sincerely appreciate the support of the physicians and nurses of the Labor and Delivery Ward at John Sealy Hospital, the teaching hospital at the University of Texas Medical Branch, Galveston, Texas, nursing coordinator Aimee Jackson, and the Perinatal Research Division of the Department of Obstetrics and Gynecology. Dawn Fischer, RN, from the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, is also thanked for her assistance. Erik Rytting, Tatiana N. Nanovskaya, Xiaoming Wang, Daria I. Vernikovskaya, Shannon M. Clark, Marlo Cochran, Susan M. Abdel-Rahman, Raman Venkataramanan, Steve N. Caritis, Gary D.V. Hankins, and Mahmoud S. Ahmed have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erik Rytting.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 78 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rytting, E., Nanovskaya, T.N., Wang, X. et al. Pharmacokinetics of Indomethacin in Pregnancy. Clin Pharmacokinet 53, 545–551 (2014). https://doi.org/10.1007/s40262-014-0133-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-014-0133-6

Keywords

Navigation